Atrion (ATRI) - Pangali EV/EBITDA

Atrion Corporation (ATRI) is expanding OEM collaborations with leading suppliers to develop custom systems for ophthalmology and fluid infusion. The brand is implementing ESG environmental standards by minimizing toxic plastics and waste. The business's stability is guaranteed by the humanitarian status of its products, which shields the company from geopolitical shocks. This EV/EBITDA chart on GURU.Markets captured a value of , visualizing the market valuation of this medtech manufacturer.

This indicator determines the total business value by combining market capitalization and net debt, divided by operating profit before depreciation. By analyzing the Enterprise Value to EBITDA multiple, an investor separates real production efficiency from the impact of taxes and loans. For the conservative Atrion Corporation (ATRI), with its capital-intensive engineering and social security costs for technical staff, this metric confirms the resilience of its fundamental assets.